HIGHLIGHTSAn additional confirmed partial response has been recorded in the ongoing ACCENT trialThis brings the confirmed Objective Response Rate ...

The latest announcement is out from Amplia Therapeutics ( ($AU:ATX) ). Amplia Therapeutics announced a positive development in its ACCENT trial ...

In a bold move, the Chief Minister of Assam has announced that splitting the Dima Hasao district into two is under serious consideration. Conversations with the North Cachar Hills Autonomous Council ...

In what’s estimated to be a $5 billion industry, a raft of businesses has grown to help customers navigate and exploit airline-linked benefits.

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

Speaking in Windhoek on 3 December 2025, President Nandi-Ndaitwah, who was inaugurated on 21 March 2025 as Namibia’s fifth and first female Head of State, made the call during a courtesy visit by SADC ...

After two days of evidence and testimonies presented from witnesses and experts around the ecocide, genocide, and forced starvation of the Palestinian people in Gaza, the “Right to Resist” ...

After two days of intense hearings, coincidence of in-person and online testimonies, the Tribunal delivered its verdict to ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...